Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.
Adjuvant therapy for breast cancer is any treatment given after primary treatment to increase the chance of long-term survival. This may can include chemotherapy, radiotherapy or hormonal therapy.
| Name | Drug Class | Updated |
|---|---|---|
| Epirubicin | Antibiotics / antineoplastics | 16-Aug-2023 |
| Neratinib | EGFR inhibitors | 14-Aug-2023 |
| Trastuzumab | HER2 inhibitors | 12-Aug-2023 |
| Tamoxifen | Hormones / antineoplastics | 12-Aug-2023 |
| Paclitaxel | Mitotic inhibitors | 11-Aug-2023 |
| Leuprolide | Gonadotropin releasing hormones | 11-Aug-2023 |
| Letrozole | Aromatase inhibitors | 11-Aug-2023 |
| Soltamox | Hormones / antineoplastics | 05-Aug-2023 |
| Trazimera | HER2 inhibitors | 14-Jul-2023 |
| Taxol | Mitotic inhibitors | 14-Jul-2023 |
| Onxol | Mitotic inhibitors | 13-Jul-2023 |
| Ontruzant | HER2 inhibitors | 13-Jul-2023 |
| Ogivri | HER2 inhibitors | 13-Jul-2023 |
| Kanjinti | Drugs | 13-Jul-2023 |
| Herzuma | HER2 inhibitors | 13-Jul-2023 |
| Ellence | Antibiotics / antineoplastics | 13-Jul-2023 |
| Nerlynx | EGFR inhibitors | 11-Jul-2023 |
| Herceptin | HER2 inhibitors | 10-Jul-2023 |
| Femara | Aromatase inhibitors | 10-Jul-2023 |